等待開盤 01-29 09:30:00 美东时间
+0.040
+0.54%
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
2025-11-26 10:07
Wedbush analyst Martin Fan assumes ImageneBio (NASDAQ:IMA) with a Underperform rating and announces Price Target of $2.
2025-11-25 22:03
ImageneBio, Inc. (Nasdaq: IMA, "Imagene," or the "Company"), a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases, including IMG-007, an
2025-11-12 20:18
ImageneBio (NASDAQ:IMA) reported quarterly losses of $(2.91) per share which missed the analyst consensus estimate of $(1.28) by 127.34 percent. This is a 12.79 percent decrease over losses of $(2.58) per share from the
2025-11-12 20:17
今日重点评级关注:HC Wainwright & Co.:维持Alto Neuroscience"买入"评级,目标价从10美元升至50美元;RBC Capital:维持Precision Drilling"跑赢大市"评级,目标价从110美元升至117美元
2025-10-27 09:45
Leerink Partners analyst David Risinger initiates coverage on ImageneBio (NASDAQ:IMA) with a Outperform rating and announces Price Target of $30.
2025-10-24 18:36
The latest update is out from ImageneBio ( ($IMA) ). On October 10, 2025, Image...
2025-10-11 05:18
The latest update is out from Image Resources NL ( ($AU:IMA) ). Image Resources...
2025-10-07 15:47
Image Resources NL ( ($AU:IMA) ) has shared an update. Image Resources NL has r...
2025-09-24 11:38